Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Other: Pulmonary Rehabilitation
- Registration Number
- NCT02542826
- Lead Sponsor
- McGill University
- Brief Summary
This is a multi-site collaborative study that will be done in the context of three Quebec hospitals' outpatient pulmonary rehabilitation programs: Montreal Chest Institute; University of Laval, and Hopital Sacre-Coeur Montreal. The objectives are two-fold. First, to determine the Minimal Clinical Important Difference in intensity ratings of perceived breathlessness for each of the 3-min constant rate shuttle walking (3-MWT) and stair stepping (3-MST) protocols in patients with chronic obstructive pulmonary disease (COPD). Second, to test the hypothesis that both the 3-MWT and 3-MST protocols are able to detect statistically significant and clinically-meaningful improvements in exertional breathlessness following an 7-12 week outpatient rehabilitative exercise training program in COPD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Male or Female
- Ambulatory
- Moderate-to-very severe COPD (GOLD Stage 2-4)
- Respiratory exacerbation in the previous 6 weeks
- Change in medication dosage/frequency in the previous 6 weeks
- Clinical evidence of asthma
- Cardiovascular and/or neuromuscular diseases that are unstable and/or that may contribute to exercise limitation
- Any other contraindications to exercise training/testing
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pulmonary Rehabilitation Pulmonary Rehabilitation -
- Primary Outcome Measures
Name Time Method Minimal clinically important difference (MCID) with regards to the change in breathlessness intensity ratings at the end of each of the 3-MST and 3-MWT. Baseline and 7 weeks
- Secondary Outcome Measures
Name Time Method Change (post- minus pre- pulmonary rehab) in dyspnea intensity ratings on the Borg 0-10 ratio category scale Baseline and 7 weeks Borg 0-10 category ratio scale
Trial Locations
- Locations (1)
McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre
🇨🇦Montreal, Quebec, Canada